- Mavyret is intended to treat adults with all types of chronic hepatitis C virus with mild or no cirrhosis who have not previously received treatment for the
illness.
- Besponsa is used to treat adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia.
- Vyxeos is intended to treat adults with two types of high-risk acute myeloid leukemia.
- Lynaparza may now be used for the ongoing treatment of patients with recurrent ovarian cancer who have responded to platinum-based chemotherapy.
- Serrato Pedicle Screw is intended for use in non-cervical procedures with the Xia 3 Spinal System.
More articles on supply chain:
7 must-reads for supply chain leaders this week
Mylan finalizes $465 million settlement with DOJ over EpiPen rebates
CDC: Yellow fever vaccine out of stock
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
